XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows provided by (used in) operating activities    
Net loss $ (2,006,543) $ (5,002,711)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 7,282 20,831
Accrued expenditures for government grant 26,419 (27,044)
Accrued interest income, related party 2,550
Loss (gain) on warrant liabilities (1,147,882) 619,989
Change in fair value of bonus rights liability 11,213 (84,125)
Provision for loan losses 55,000
Impairment of intangible assets 39,166
Reallocation of equipment to commercial operations 18,000
Share-based compensation 1,355,373 348,085
Shares issued for services 2,273,949
Changes in non-cash operating working capital items:    
Accounts receivable, net (422,796)
Inventories (268,243)
Prepaid expenses and other current assets (163,950) (213,439)
Accounts payable and accrued liabilities 128,572 (503,743)
Deferred income 418,275
Net cash provided by (used in) operating activities (2,044,280) (2,471,492)
Cash flows (used in) investing activities    
Acquisition of equipment (63,270)
Net cash (used in) investing activities (63,270)
Cash flows provided by (used in) financing activities    
Units issued for cash 3,732,469
Repayment of promissory notes (911,463)
Proceeds received from restricted government grant 174,675 180,000
Amounts paid from restricted government grant funds (97,515) (106,735)
Share issuance costs (405,753)
Net cash provided by (used in) financing activities (834,303) 3,399,981
Change in cash and cash equivalents during the period (2,941,853) 928,489
Cash and cash equivalents, beginning of period 48,564,082 1,494,573
Cash and cash equivalents, end of period 45,622,229 2,423,062
Cash and cash equivalents consists of:    
Demand deposits 45,527,197 852,296
Term deposit 1,407,088
Restricted cash 95,032 163,678
Total cash and cash equivalents 45,622,229 2,423,062
Supplemental Disclosure    
Cash paid for interest 4,894 16,612
Supplemental non-cash disclosures    
Reallocation of fair value of share options upon exercise 36,751
Reclassification of derivative liability for warrants re-priced from CAD to USD exercise price 3,942,575
Common shares issued for share issuance costs 928,874
Warrants issued for share issuance costs $ 582,245